Medical News

RSS

Aston University researchers receive stimulus funds to study fundamental processes of human vision

A team of researchers led by Professor Mark Georgeson and Dr Timothy Meese at Aston University in Birmingham, UK have been awarded over £1 million pounds worth of funding from the BBSRC (Biotechnology and Biological Sciences Research Council) and the EPSRC (Engineering and Physical Sciences Research Council) to investigate some of the fundamental processes involved in human vision.

8 Dec 2009

Also in global health news: Clean water in India; cholera in Kenya; Zuma, Gates discuss HIV/AIDS; MDR-TB in Marshall Islands; sanitation in Jakarta

India's Tata Group on Monday "unveiled a new low-cost water purifier, which it hopes will provide safe drinking water for millions and cut the toll of deadly diseases," Agence France-Presse/mysinchew.com reports.

8 Dec 2009

Researchers identify gene expression and biological pathways for healing gingivitis

Gingivitis, which may affect more than one-half of the U.S. adult population, is a condition commonly attributed to lapses in simple oral hygiene habits. However, a new study shows that development and reversal of gingivitis at the molecular level is apparently much more complicated than its causes might indicate.

8 Dec 2009

Phase II clinical trial results reveal positive effects of omacetaxine against CML

Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. D. Anderson Cancer Center report today at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

5AM Venture Management closes $200 million venture capital fund

5AM Venture Management, LLC of Menlo Park, CA and Waltham, MA is pleased to announce the closing of 5AM Ventures III, L.P., a $200 million venture capital fund focused on early-stage life science companies.

8 Dec 2009

ThermoGenesis enters into material transfer agreement with GID Group

ThermoGenesis Corp., a leading supplier of innovative products for processing and storing adult stem cells, said today it has entered into a material transfer agreement with the GID Group which has been working with ThermoGenesis to use ThermoGenesis' MarrowXpress(TM), or MXP(TM), based technology for the processing of adipose, or fatty, tissue - a rich source of adult stem cells.

8 Dec 2009

Individuals taking antidepressants may experience personality change, says new report

Individuals taking a medication to treat depression may experience changes in their personality separate from the alleviation of depressive symptoms, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

8 Dec 2009

Antiepileptic drugs may have a possible protective effect against seizure disorders

Despite government warnings about an increased risk of suicidal thoughts and actions while taking antiepileptic drugs, these medications do not appear to be associated with increased risk of suicide attempts in individuals with bipolar disorder, and may have a possible protective effect, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

8 Dec 2009

U.S. bishops recommend the Senate to support Nelson-Hatch-Casey amendment

The U.S. bishops have voiced support for the Nelson-Hatch-Casey Amendment to the Senate health reform bill and have asked voters to back it.

8 Dec 2009

NEXUS Biosystems acquires Aurora Biotechnologies

NEXUS Biosystems, Inc. (“Nexus”), a leading innovator and worldwide provider of automated sample management systems, today announced the acquisition of Aurora Biotechnologies of Carlsbad, CA (“Aurora”), a leading developer of proprietary high performance microplates for use in sample storage, high-throughput screening, and cellular imaging.

8 Dec 2009

Celldex Therapeutics to present poster on its first antibody-drug conjugate product

Celldex Therapeutics, Inc. today announced that the Company’s first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.

8 Dec 2009

Social isolation and stress can raise breast cancer risk

Social isolation and related stress could contribute to human breast cancer susceptibility, research from a rat model designed at the University of Chicago to identify environmental mechanisms contributing to cancer risk shows.

8 Dec 2009

iRGD peptide found to enhance both cancer detection and treatment

Researchers at Burnham Institute for Medical Research at University of California, Santa Barbara have identified a peptide (a chain of amino acids) that specifically recognizes and penetrates cancerous tumors but not normal tissues.

8 Dec 2009

bioMerieux announces the upcoming availability of ABxAlert from ICNet International

bioMerieux, a world leader in the field of in vitro diagnostics, announced the upcoming availability of ABxAlert® from ICNet International Ltd., a global clinical informatics company, at the 44th American Society of Health-System Pharmacists Midyear Clinical Meeting and Exhibition.

8 Dec 2009

The big health reform issues bedeviling Harry Reid

Kaiser Health News staff writer Mary Agnes Carey reports on the outlook in the Senate during its weekend session and Majority Leader Harry Reid's continuing efforts to advance the cause.

8 Dec 2009

Results of preclinical studies evaluating AC220 to be presented at ASH annual meeting

Ambit Biosciences Corporation announced today the presentation of two posters presenting the results of preclinical studies evaluating AC220 at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans.

8 Dec 2009

Study suggests sustained health risks linked to adverse childhood experiences

Research from the Institute of Psychiatry at King's College London has found that negative experiences in childhood may alter not only mental health but also physical health, into middle age and beyond.

8 Dec 2009

Carfilzomib shows noteworthy responses and low side effects among multiple myeloma patients

The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers reported today at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

Cyntellect and Boston University sign research collaboration agreement

Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today announced it has entered into a research collaboration agreement with the Boston University School of Medicine.

8 Dec 2009

Workforce Alliance receives $134,790 grant to fund workforce training program

Workforce Alliance was awarded a $134,790 grant by the State of Florida to fund a workforce training program aimed at meeting the high need for skilled health care workers in Palm Beach County.

8 Dec 2009

Medical News

Aston University researchers receive stimulus funds to study fundamental processes of human vision

Also in global health news: Clean water in India; cholera in Kenya; Zuma, Gates discuss HIV/AIDS; MDR-TB in Marshall Islands; sanitation in Jakarta

Researchers identify gene expression and biological pathways for healing gingivitis

Phase II clinical trial results reveal positive effects of omacetaxine against CML

5AM Venture Management closes $200 million venture capital fund

ThermoGenesis enters into material transfer agreement with GID Group

Individuals taking antidepressants may experience personality change, says new report

Antiepileptic drugs may have a possible protective effect against seizure disorders

U.S. bishops recommend the Senate to support Nelson-Hatch-Casey amendment

NEXUS Biosystems acquires Aurora Biotechnologies

Celldex Therapeutics to present poster on its first antibody-drug conjugate product

Social isolation and stress can raise breast cancer risk

iRGD peptide found to enhance both cancer detection and treatment

bioMerieux announces the upcoming availability of ABxAlert from ICNet International

The big health reform issues bedeviling Harry Reid

Results of preclinical studies evaluating AC220 to be presented at ASH annual meeting

Study suggests sustained health risks linked to adverse childhood experiences

Carfilzomib shows noteworthy responses and low side effects among multiple myeloma patients

Cyntellect and Boston University sign research collaboration agreement

Workforce Alliance receives $134,790 grant to fund workforce training program

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News